TABLE 4.
Author (Year) | Title | Study type | Sample characteristics | Index laboratory testing | Biases |
---|---|---|---|---|---|
Ferenci et al. (2005) 17 | Diagnostic value of quantitative hepatic copper determination in patients with Wilson's disease | Case control* | Individuals with WD, of neuropsychiatric, hepatic, or asymptomatic type, controls without WD and participants with other hepatic pathologies | Hepatic copper was measured by atomic absorption spectroscopy | Given the non‐randomized enrollment and observational nature of the study, potential biases may have existed |
Lu et al. (2010) 16 | The reassessment of the diagnostic value of 24‐hour urinary copper excretion in children with Wilson's disease | Case control* | The individuals had unknown hepatic pathologies | 24‐hour urinary copper was measured by ICP mass spectrometry | Non‐randomization, selection bias of the case‐control design may have led to bias |
Mak et al. (2008) 15 | Diagnostic accuracy of serum ceruloplasmin in Wilson's disease: determination of sensitivity and specificity by ROC curve analysis among ATP7B‐genotyped subjects | Case control* | Individuals with WD of neuropsychiatric, hepatic, or asymptomatic type, groups with no diagnosis of hepatic or neurological deficit, and normal controls | Ceruloplasmin with nephelometry Beckman Coulter IMMAGE | The nature of clinical reference standards in addition to non‐randomization and low acceptability of results with small sample size may lead to the risk of bias |
Merle et al. (2009) 14 | Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson's disease | Case control* | Individuals with WD, neurological or hepatic, with alternative hepatic pathologies, or normal controls | Ceruloplasmin nephelometry Dade Behring | Sample selection, non‐randomization, and case‐control amplify the risk of bias |
Nicastro et al. (2010) 11 | Re‐evaluation of the diagnostic criteria for Wilson's disease in children with mild liver disease | Case control* | Confirmed WD patients either with asymptomatic family screening or hepatic etiology, with alternative hepatic pathologies, or normal controls | Hepatic copper with flame absorption spectrophotometry; urine copper using flame absorption spectrophotometry; ceruloplasmin using radial immunodiffusion NOR‐Partigen Behring | Case‐control study type increases the risk of non‐randomization and less diverse sample set |
Sezer et al. (2014) 12 | Is it necessary to re‐evaluate diagnostic criteria for Wilson's disease in children? | Case control* | Patients with hepatic WD, alternative hepatic pathologies, or normal controls | Ceruloplasmin by immunoturbidimetry Roche Modular; urine copper with atomic absorption spectrophotometry AA‐6701F Shimadzu; and hepatic copper by atomic absorption spectrophotometry AA‐6701F Shimadzu | Selection bias, non‐randomization bias may increase the risk of bias or confounders |
Xu et al. (2018) 13 | The optimal threshold of serum ceruloplasmin in the diagnosis of Wilson's disease: A large hospital‐based study | Cross‐sectional | Patients that underwent ceruloplasmin analysis were eligible to be included, and the tests/records were noted in a hospital center | Beckman Coulter Immage; ceruloplasmin using nephelometry | The cross‐sectional study design leads to increase the risk of selection bias |
Yang et al. (2015) 18 | Prospective evaluation of the diagnostic accuracy of hepatic copper content, as determined using the entire core of a liver biopsy sample | Prospective cohort | Patients with suspected hepatic WD, family member of people with confirmed WD, or those that had alternative hepatic pathologies | Hepatic copper using atomic absorption spectrophotometry Beijing Purkinje General Instruments | The study had the minimal risk of bias, and the population was most reflective of clinical practice |
Zarina et al. (2019) 21 | Association of Variants in the CP, ATOX1, and COMMD1 genes with Wilson's disease symptoms in Latvia | Genetic prospective cohort | Patients with WD: asymptomatic, hepatic, neurological/psychiatric, and neurological/hepatic | Direct sequences of the ATOX1, COMMD1, and CP genes; direct DNA sequencing of the ATP7B gene | The study had the minimal risk of bias other than the relatively less sample size as compared to a large genetic cohort study |
*All patients were being tested for WD, and the Leipzig criteria were the standard of reference.